Patent US4920986A successfully refreshed from Google Patents.
Patent US5364389A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4201773A Expired / Lapsed US ⏱️ 0.0 years remaining

7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone

Assignee: United States Department of Health and Human Services
•
Filing: 1978-07-26
•
Granted: 1980-05-06
•
Expires: 1998-07-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A series of compounds showing high antileukemic activity against P388 murine leukemia and increased aqueous solubility due to substitution of -OH for the known -NH2 at the 3' position of the hexopyranose sugar, i.e., daunosamine. These compounds are coupled products of aglycon selected from daunomycinone, desmethoxy daunomycinone, adriamycinone and carminomycinone. These compounds are coupled at the 0-7 position of the aglycon with an alpha -L-lyxo hexopyranose sugar, which sugar isomer particularly sustains or potentiates the biological activity of the coupled compound as well as ameliorates the dose related cardiotoxicity of the parent and known compounds set out below: <IMAGE>

Inventors

  • 👤 Derek Horton
  • 👤 Wolfgang Weckerle
  • 👤 Ernst F. Fuchs
  • 👤 Tak M. Cheung
  • 👤 Beat Winter
  • 👤 Roderick J. Sorenson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:10
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/02; C07H15/04; A; A61; A61P; A61P31/00; A61P31/04; A61P35/00; A61P35/02; C07H13/00; C07H13/02; C07H13/04; C07H15/20; C07H15/24; C07H15/252; C07H3/00; C07H3/02

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 45 words
A compound selected from one member of the group of aglycons consisting of daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone coupled at the 0-7 position to a 3' desamino α-L-lyxo hexose sugar at the 1' position of the sugar molecule according to the following formula: ##STR6##
Claim 2
Dependent Claim 45 words
A compound selected from one member of the group of aglycons consisting of daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone coupled at the 0-7 position to a 3' desamino α-L-lyxo hexose sugar at the 1' position of the sugar molecule according to the following formula: ##STR6##
Claim 3
Dependent Claim 12 words
The compound according to claim 1 wherein the aglycon utilized is daunomycinone.
Claim 4
Dependent Claim 13 words
The compound according to claim 1 wherein the aglycon utilized is desmethoxy daunomycinone.
Claim 5
Dependent Claim 12 words
The compound according to claim 1 wherein the aglycon utilized is adriamycinone.
Claim 6
Dependent Claim 12 words
The compound according to claim 1 wherein the aglycon utilized is carminomycinone.
Claim 7
Independent Claim 38 words
A method of treating murine leukemia in mice which comprises injecting a mouse infected with P388 leukemia with a biologically palliative amount and in a dosage regimen of up to 22 days of a compound selected from ##STR7##
Claim 8
Independent Claim 38 words
A method of treating murine leukemia in mice which comprises injecting a mouse infected with P388 leukemia with a biologically palliative amount and in a dosage regimen of up to 22 days of a compound selected from ##STR7##
Claim 9
Dependent Claim 11 words
The method of claim 6 wherein the aglycon utilized is daunomycinone.
Claim 10
Dependent Claim 12 words
The method of claim 6 wherein the aglycon utilized is desmethoxy daunomycinone.
Claim 11
Dependent Claim 11 words
The method of claim 6 wherein the aglycon utilized is adriamycinone.
Claim 12
Dependent Claim 11 words
The method of claim 6 wherein the aglycon utilized is carminomycinone.
Claim 13
Dependent Claim 18 words
The compound according to claim 1 wherein the 3'-desamino α-L-lyxo hexose sugar is in the following configuration ##STR8##

References Cited (Backward Citations)

GB1161278A Cited
US3590028A Cited
GB1217133A Cited
US3803124A Cited
US4058519A Cited
US4046878A Cited
US4067969A Cited
US4067968A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-05-06 1983-11-05 1984-05-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-05-06 1987-11-05 1988-05-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-05-06 1991-11-05 1992-05-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag